tiprankstipranks

Todd Davis Insider Profile

4 Followers
Todd Davis, CEO, Director at Ligand Pharma, holds 120.16K shares in Ligand Pharma (Ticker: LGND), holds 29.17K shares in Chromocell Therapeutics Corp (Ticker: CHRO), holds 125.91K shares in Vaxart (Ticker: VXRT). Most recently, Todd Davis Bought ― shares of Ligand Pharma on Mar 27, 2024 for an estimated value of 919.15K.
tipranks
Todd Davis

Todd Davis
Ligand Pharma (LGND)
CEO, Director

Ranked #81,367 out of 98,564 Corporate Insiders

Profitable Transactions

73%
11 out of 15 Profitable Transactions

Average Return

-13.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$9M
98.37%
1.10%
0.53%
A breakdown of Todd Davis's holdings

Insider Roles

Ligand Pharma
(LGND)
CEO, Director
Vaxart
(VXRT)
Director
Chromocell Therapeutics Corp
(CHRO)
Director
Roles that Todd Davis holds in companies

Most Profitable Insider Trade

Stock:
Ligand Pharma
(LGND)
Rating:Informative Buy
Date:Nov 01, 2016 - Nov 01, 2017
Return:+50.10%
The most profitable trade made by Todd Davis

Todd Davis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ligand Pharma
Mar 27, 2024
CEO, Director
Informative Buy
919.15K
$8.40M
BDSI
BioDelivery
Mar 22, 2022
Uninformative Sell
$0.00
Vaxart
Aug 08, 2022
Director
Uninformative Buy
$93.80K
Chromocell Therapeutics Corp
Feb 23, 2024
Director
Informative Buy
140.00K
$45.50K
List of latest transactions for each holding click on a transaction to see Todd Davis's performance on stock

Todd Davis insider profile FAQ

What is the percentage of profitable transactions made by Todd Davis?
The percentage of profitable transactions made by Todd Davis is 73%.
    What is the average return per transaction made by Todd Davis?
    The average return per transaction made by Todd Davis is -13.20%.
      What stocks does Todd Davis hold?
      Todd Davis holds: LGND, BDSI, VXRT, CHRO stocks.
        What was Todd Davis’s latest transaction?
        Todd Davis latest transaction was an Informative Buy of $919.15K.
          What was Todd Davis's most profitable transaction?
          Todd Davis’s most profitable transaction was an Informative Buy of LGND stock on November 1, 2016. The return on the trade was 50.10%.
            What is Todd Davis's role in Ligand Pharma?
            Todd Davis's role in Ligand Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.